AnalystsReni J. Benjamin
Reni J. Benjamin's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 11%
#4750 out of 5296 analysts
Average Return
-3.09%
Win Rate
32%8 out of 25
Risk vs Reward
Poor
Good

Reni J. Benjamin's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Prelude Therapeutics IncPRLD
+375.64%$0.94$4.49
2025-08-18 -
2026-06-12
Buy
Kura Oncology IncKURA
+63.36%$5.54$9.05
2025-08-11 -
2026-06-12
Buy
Bicara Therapeutics IncBCAX
+28.27%$16.91$21.69
2026-01-29 -
2026-06-12
Buy
Compass Therapeutics IncCMPX
+10.33%$1.84$2.03
2026-04-28 -
2026-06-12
Buy
Bicara Therapeutics IncBCAX
+9.05%$19.89$21.69
2026-03-31 -
2026-06-12
Buy

Reni J. Benjamin Analyst Color

Get additional color on Reni J. Benjamin's coverage of popular stocks

Reni J. Benjamin's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Compass Therapeutics IncCMPX
1Buy$10.00+392.61%Reiterates
2 months ago
Sutro Biopharma IncSTRO
2Buy$41.00+42.36%Maintains
2 months ago
Whitehawk Therapeutics IncWHWK
1Buy$8.00+92.31%Initiates Coverage On
2 months ago
Allogene Therapeutics IncALLO
1Buy$8.00+321.05%Maintains
2 months ago
Bicara Therapeutics IncBCAX
2Buy$31.00+42.92%Reiterates
2 months ago
IMMIX Biopharma IncIMMX
1Buy$23.00+172.19%Reiterates
3 months ago
Lyell Immunopharma IncLYEL
1Buy$34.00+151.85%Initiates Coverage On
3 months ago
Iovance Biotherapeutics IncIOVA
2Buy$5.00+22.55%Upgrades
3 months ago
Immutep LtdIMMP
2Buy$10.00+2,647.25%Initiates Coverage On
4 months ago
Summit Therapeutics IncSMMT
4Buy$40.00+185.51%Reiterates
4 months ago
Zymeworks IncZYME
1Buy$32.00+39.86%Initiates Coverage On
6 months ago
Beone Medicines LtdONC
1Buy$396.00+49.73%Maintains
7 months ago
Sana Biotechnology IncSANA
1Buy$8.00+198.51%Maintains
7 months ago
Kura Oncology IncKURA
2Buy$24.00+165.19%Reiterates
8 months ago
Werewolf Therapeutics IncHOWL
1Buy$3.00+687.40%Maintains
10 months ago
Prelude Therapeutics IncPRLD
1Buy$3.00-33.18%Maintains
10 months ago
Bicycle Therapeutics PLCBCYC
1Buy$10.00+146.91%Maintains
10 months ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.